Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Mather

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2002
VirRAD-a "virtual" radiopharmacy learning community: your input neededStephen J Mather
Nuclear Medicine Communications|April 21, 2004
99Tc peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumoursStephen J Mather
Molecular Biosystems|January 12, 2007
Design of radiolabelled ligands for the imaging and treatment of cancerStephen J Mather
Nuclear Medicine Review. Central & Eastern Europe|August 20, 2004
VirRAD--a virtual learning resource for radiopharmacy and nuclear medicineStephen J Mather
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2017
IAEA Technical Report SeriesStephen J Mather, Luigi Mansi
Nuclear Medicine Communications|December 13, 2006
Investigative clinical studies with radiopharmaceuticalsKeith Harding, Stephen J Mather
Nature Protocols|April 5, 2007
Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopesJane K Sosabowski, Stephen J Mather
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2012
Pathogen identification by nuclear imaging--almost there?Samir G Agrawal, Stephen J Mather
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2005
Regressive DOTA labelling performance with indium-111 and yttrium-90 over a week of useJames E S Hainsworth, Stephen J Mather
Bioconjugate Chemistry|November 17, 2005
Preparation and characterization of a DOTA-lysine-biotin conjugate as an effector molecule for pretargeted radionuclide therapyJames Hainsworth, Peter Harrison, Stephen J Mather
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2002
VirRAD-a "virtual" radiopharmacy learning community: your input neededStephen J Mather
Nuclear Medicine Communications|April 21, 2004
99Tc peptide-peptide nucleic acid probes for imaging oncogene mRNAs in tumoursStephen J Mather
Molecular Biosystems|January 12, 2007
Design of radiolabelled ligands for the imaging and treatment of cancerStephen J Mather
Nuclear Medicine Review. Central & Eastern Europe|August 20, 2004
VirRAD--a virtual learning resource for radiopharmacy and nuclear medicineStephen J Mather
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2017
IAEA Technical Report SeriesStephen J Mather, Luigi Mansi
Nuclear Medicine Communications|December 13, 2006
Investigative clinical studies with radiopharmaceuticalsKeith Harding, Stephen J Mather
Nature Protocols|April 5, 2007
Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopesJane K Sosabowski, Stephen J Mather
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2012
Pathogen identification by nuclear imaging--almost there?Samir G Agrawal, Stephen J Mather
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2005
Regressive DOTA labelling performance with indium-111 and yttrium-90 over a week of useJames E S Hainsworth, Stephen J Mather
Bioconjugate Chemistry|November 17, 2005
Preparation and characterization of a DOTA-lysine-biotin conjugate as an effector molecule for pretargeted radionuclide therapyJames Hainsworth, Peter Harrison, Stephen J Mather
Pageof 6